Preventative Medicine: Co-occurring conditions during pregnancy and hospitalizations in the first year postpartum among persons with opioid use disorder

Co-occurring conditions during pregnancy and hospitalizations in the first year postpartum among persons with opioid use disorder – ScienceDirect Introduction Pregnant persons with opioid use disorder (OUD) face a multitude…

Read More from Preventative Medicine: Co-occurring conditions during pregnancy and hospitalizations in the first year postpartum among persons with opioid use disorder

Pediatrics Review: Advances in the Care of Infants With Prenatal Opioid Exposure and Neonatal Opioid Withdrawal Syndrome

SOURCE: Mascarenhas, M. et al. Advances in the Care of Infants With Prenatal Opioid Exposure and Neonatal Opioid Withdrawal Syndrome. Pediatrics 2024; e2023062871. 10.1542/peds.2023-062871 A significant number of advances have…

Read More from Pediatrics Review: Advances in the Care of Infants With Prenatal Opioid Exposure and Neonatal Opioid Withdrawal Syndrome

Using the Eat Sleep Console Model to Promote Optimal Care and Outcomes for Infants With Neonatal Abstinence Syndrome: A Nurse-Driven, Multidisciplinary Initiative

SOURCE: Haaland, Grace BSN, RN, RNC-NIC; Kunkel, Melissa MD, MS; Nguyen, Chi Mai PhD; Wonder, Amy Hagedorn PhD, RN. Using the Eat Sleep Console Model to Promote Optimal Care and…

Read More from Using the Eat Sleep Console Model to Promote Optimal Care and Outcomes for Infants With Neonatal Abstinence Syndrome: A Nurse-Driven, Multidisciplinary Initiative

CHESS Health Referral Service Now Available for Oklahoma Providers – Webinars Nov. 11 and 19

CHESS Health eIntervention services are now available to Oklahoma providers. eIntervention is a web-based, flexible, closed-loop referral management platform, optimized for behavioral health. Individuals and family members are connected with…

Read More from CHESS Health Referral Service Now Available for Oklahoma Providers – Webinars Nov. 11 and 19

JOGNN: Evaluation of a Nurse-Led Program for Rural Pregnant Women With Opioid Use Disorder to Improve Maternal–Neonatal Outcomes

SOURCE: Paterno, Mary T. et al. Evaluation of a Nurse-Led Program for Rural Pregnant Women With Opioid Use Disorder to Improve Maternal–Neonatal Outcomes. Journal of Obstetric, Gynecologic & Neonatal Nursing, Volume…

Read More from JOGNN: Evaluation of a Nurse-Led Program for Rural Pregnant Women With Opioid Use Disorder to Improve Maternal–Neonatal Outcomes

AWHONN Position Statement: Optimizing Outcomes for Women With Substance Use Disorders in Pregnancy and the Postpartum Period

SOURCE: Association of Women’s Health, Obstetric, and Neonatal Nurses. Optimizing Outcomes for Women With Substance Use Disorders in Pregnancy and the Postpartum Period. JOGNN, DOI: 10.1016/j.jogn.2019.06.001 ABSTRACT: The Association of…

Read More from AWHONN Position Statement: Optimizing Outcomes for Women With Substance Use Disorders in Pregnancy and the Postpartum Period

Pediatrics Review Article: Prenatal Opioid Exposure: Neurodevelopmental Consequences and Future Research Priorities

SOURCE: Elisabeth Conradt, et al, Prenatal Opioid Exposure: Neurodevelopmental Consequences and Future Research Priorities, Pediatrics Aug 2019, e20190128; DOI: 10.1542/peds.2019-0128 ABSTRACT: Neonatal opioid withdrawal syndrome (NOWS) has risen in prevalence from 1.2…

Read More from Pediatrics Review Article: Prenatal Opioid Exposure: Neurodevelopmental Consequences and Future Research Priorities

Pediatrics Commentary: Fetal Opioid Exposure and Smaller Birth Head Circumference: Cause for Concern?

Mark Hudak, MD and Kartikeya Makker, MD offer commentary on the concurrently released study in Pediatrics, Neonatal Head Circumference in Newborns With Neonatal Abstinence Syndrome, in which infants of mothers undergoing…

Read More from Pediatrics Commentary: Fetal Opioid Exposure and Smaller Birth Head Circumference: Cause for Concern?

Prescription Monitoring Program (PMP): Mandatory check required beginning Nov. 1

HB 1948, Prescription Monitoring Program (PMP) goes into effect November 1, 2015.  The legislation clarifies language related to the Uniform Controlled Dangerous Substance Act and establishes a Prescription Monitoring Program…

Read More from Prescription Monitoring Program (PMP): Mandatory check required beginning Nov. 1